JP2008504355A - 癌の処置 - Google Patents

癌の処置 Download PDF

Info

Publication number
JP2008504355A
JP2008504355A JP2007518687A JP2007518687A JP2008504355A JP 2008504355 A JP2008504355 A JP 2008504355A JP 2007518687 A JP2007518687 A JP 2007518687A JP 2007518687 A JP2007518687 A JP 2007518687A JP 2008504355 A JP2008504355 A JP 2008504355A
Authority
JP
Japan
Prior art keywords
cancer
leukemia
combination preparation
hsp90
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007518687A
Other languages
English (en)
Japanese (ja)
Inventor
バーニー・ジェームス・ピーター
マシューズ・ルース・クリスティン
カーター・トレイシー
Original Assignee
ニュウテック ファーマ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0414885A external-priority patent/GB0414885D0/en
Priority claimed from GB0420845A external-priority patent/GB0420845D0/en
Priority claimed from GB0503566A external-priority patent/GB0503566D0/en
Application filed by ニュウテック ファーマ リミテッド filed Critical ニュウテック ファーマ リミテッド
Priority claimed from PCT/GB2005/002545 external-priority patent/WO2006003384A1/en
Publication of JP2008504355A publication Critical patent/JP2008504355A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
JP2007518687A 2004-07-02 2005-06-30 癌の処置 Pending JP2008504355A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
GB0420845A GB0420845D0 (en) 2004-09-20 2004-09-20 Treatment of cancer
US61442304P 2004-09-30 2004-09-30
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer
US65445805P 2005-02-22 2005-02-22
PCT/GB2005/002545 WO2006003384A1 (en) 2004-07-02 2005-06-30 Treatment of cancer

Publications (1)

Publication Number Publication Date
JP2008504355A true JP2008504355A (ja) 2008-02-14

Family

ID=39124615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007518687A Pending JP2008504355A (ja) 2004-07-02 2005-06-30 癌の処置

Country Status (8)

Country Link
JP (1) JP2008504355A (es)
BR (1) BRPI0512889A (es)
EC (1) ECSP077219A (es)
IL (1) IL180460A (es)
MA (1) MA28701B1 (es)
MX (1) MX2007000263A (es)
NZ (1) NZ552508A (es)
SG (1) SG153877A1 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530357A (ja) * 2000-04-06 2003-10-14 ニュウテック ファーマ パブリック リミテッド カンパニー 抗ｈｓｐ抗体と組み合わせたポリエンまたはβグルカンシンターゼインヒビター抗真菌薬での真菌感染症の治療

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530357A (ja) * 2000-04-06 2003-10-14 ニュウテック ファーマ パブリック リミテッド カンパニー 抗ｈｓｐ抗体と組み合わせたポリエンまたはβグルカンシンターゼインヒビター抗真菌薬での真菌感染症の治療

Also Published As

Publication number Publication date
MX2007000263A (es) 2007-07-20
BRPI0512889A (pt) 2008-04-15
SG153877A1 (en) 2009-07-29
ECSP077219A (es) 2007-03-29
NZ552508A (en) 2009-10-30
IL180460A (en) 2010-12-30
IL180460A0 (en) 2007-06-03
MA28701B1 (fr) 2007-06-01

Similar Documents

Publication Publication Date Title
RU2389507C2 (ru) Лечение рака
Karpel-Massler et al. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
Ganapathy et al. AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability
TW201032796A (en) Treatment of lung cancer with a PARP inhibitor in combination with a growth factor inhibitor
WO2019096194A1 (zh) Pd-1抗体和vegfr抑制剂联合治疗小细胞肺癌的用途
JP2010526862A (ja) がんの処置のための相乗的な医薬の組合せ
Koval et al. A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models
TW201822817A (zh) HDM2-p53交互作用抑制劑之劑量及療法
Ozawa‐Umeta et al. Curcumin β‐D‐glucuronide exhibits anti–tumor effects on oxaliplatin‐resistant colon cancer with less toxicity in vivo
Xie et al. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway
US20230011378A1 (en) Combination Therapy For Treatment Of Cancer
CN115135322A (zh) 包含哺乳动物雷帕霉素靶蛋白信号传导抑制剂作为有效成分的用于预防或治疗癌症的药物组合物
TW202034959A (zh) 抗體-藥物結合物與parp抑制劑之組合
KR20190129889A (ko) 혈액 종양에서 HDM2-p53 상호작용 억제제의 용량 및 요법
WO2022062223A1 (zh) 金诺芬在制备用于治疗去势抵抗性前列腺癌药物中的应用
Jack et al. A novel, safe, fast and efficient treatment for Her2‐positive and negative bladder cancer utilizing an EGF‐anthrax toxin chimera
CN113226320A (zh) Mdm2抑制剂的延长的低剂量方案
Zhang et al. ATG7-dependent and independent autophagy determine the type of treatment in lung cancer
Ma et al. Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy
US20220241294A1 (en) Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating notch-activated breast cancer
US8691764B2 (en) Inhibitors of NF-κB activity
US20230058171A1 (en) New oral pharmaceutical composition for cancer therapy
Poklepovic et al. Phase I study of pemetrexed with sorafenib in advanced solid tumors
JP2008504355A (ja) 癌の処置
Caponigro et al. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110315

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110809